【New Share 2506 Subscription】Information on IPO IPO of Sietfei Medical Technology

Futu Information News December 18, $ Telecom Medical Technology (02506.HK) $ Announcement that the Company intends to offer 7.0356 million shares worldwide in the public offering from 18 December 2024 to 23 December 2024, which is expected to be listed on 30 December 2024.

Telefei Medical Technology Real-time Quotation

Telefei Medical Technology Financial Profile

The Company's revenue increased 26.7% from RMB0.372 billion in 2021 to RMB0.472 billion in 2022 and increased 17.9% to RMB0.556 billion in 2023; the Company's gross profit increased 22.9% from RMB0.188 billion in 2021 to RMB0.231 billion in 2022 and increased 36.4% to RMB 2023 0.315 billion yuan.

Source: Prospectus

Industry Overview

China's healthcare industry mainly includes disease prevention, treatment and rehabilitation services. China's medical spending in 2023 is RMB9095.7 billion and is expected to increase to RMB14542.8 billion in 2030, with a compound year growth rate of 6.9%. Healthcare providers in China include primary care institutions, hospitals and other medical institutions. As of 31 December 2023, there were 1016,000 primary care institutions and 39000 hospitals in China.

The market size of China's medical artificial intelligence industry has grown significantly. It increased from RMB 2.7 billion in 2019 to RMB 8.8 billion in 2023, for a compound year growth rate of 33.8%. It is expected to grow further to RMB 315.7 billion by 2033, with a compound year growth rate of 43.1% from 2023 to 2033. In 2021, 2022 and 2023, the company ranked first by revenue, with a market share of 8.0%, 6.8% and 5.9%, respectively.

Source: Prospectus

Linefei Medical Technology Cornerstone Investor

For cornerstone investors, Star Group, Daan, Hengqin Investment Fund, Newmedical Co., Ltd., and Costone China Growth have agreed, subject to certain conditions, to subscribe or induce a total subscription amount of approximately $35.57 million at the offering price.

Source: Prospectus

Funded uses of Telefei Medical Technology

For financing purposes, NetFei Medical Technology expects net proceeds from global sales to be approximately HK$0.5071 billion (assuming an IPO price of HK$82.8). According to the offer letter, Newfly Medical Technology intends to use the global raising funds for the following purposes: approximately 32.4% will be used to invest in R&D to continuously strengthen the company's core capabilities; approximately 26.6% will be used to further enrich the company's products and services by upgrading existing products and developing new products; approximately 24.7% will be used to strengthen Commercialize capabilities and expand the company's service network; approximately 6.4% will be used to acquire companies that may have synergies with the company's existing capacity; approximately 10% will be used for working capital and other general corporate purposes.

Read more:Newfly Medical Technology Procurement

How to Get 0 Interest 0 Processing Fee Medical Technology Subscription

In Futu, it only takes three steps to buy new shares!

STEP 1: OPEN A SECURITIES ACCOUNT TO SUBSCRIBE FOR NEW SHARES

Open a combined account on Futu, click below to open now and enjoy the opening reward of over $USD.(Open an account now)

Step 2: After entering the new share center, enter the Futubull APP, select the market cap, select the Hong Kong shares, and then select the new shares you need to buy.

Step 3: Confirm order quantity and order method

Select the method you hope to purchase (Ordinary, Futures, or Bank Expansion) and enter the quantity and proceed with the purchase.

New customers open an account for a limited time and enjoy up to 1,000 mosquitoesAccount Opening Offer, seize the time to find money now!

*New share buybacks are limited to Bank Expansion, and Futu and Futu will demonstrate international earnings on the purchase page as standard.

^0Real-time fee refers to the cash purchase and/or the Futu Expansion Procurement Fee0 application fee.

#超高槓桿僅適用於特定新股。 Although high leverage can bring high returns, it also comes with some risk. Consider your risk tolerance and investment goals, and ensure you maintain sufficient assets to cope with market fluctuations.